Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
Molecular Cancer volume 22, Article number: 175 (2023)
Correction: Mol Cancer 13, 157 (2014)
Following publication of the original article , a reader reported that “two signals in Fig. 3C seem to be unexpectedly similar”, and as original blots are no longer available (only cropped versions of the triplicate blots), an alternative replicate of the Fig. 3c blot is provided in this correction. This replacement does not alter the results presented in the text. The correct figure is given below.
McDermott MSJ, Browne BC, Conlon NT, et al. PP2A inhibition overcomes acquired resistance to HER2 targeted therapy. Mol Cancer. 2014;13:157. https://doi.org/10.1186/1476-4598-13-157.
About this article
Cite this article
McDermott, M.S.J., Browne, B.C., Conlon, N.T. et al. Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy. Mol Cancer 22, 175 (2023). https://doi.org/10.1186/s12943-023-01890-z